Projects

Senior Research Fellow
RNDr. Vladimír Knezl, PhD.

National

Current
  • Neuroprotective and cardioprotective potential of phenol acids in the prevention of civilization diseases
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • Targeted suppression of pro-inflammatory and pro-fibrotic signaling pathways to prevent heart failure and occurrence of malignant arrhythmias
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
Finished
  • Are connexin channels involved in extracellular matrix remodeling of overloaded heart?
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Effect of fructose diet in experimental models of metabolic syndrome and in healthy subjects: proposal of effective pharmacological treatment
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • -
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • Investigation of regulatory mechanisms of cardiac cell-cell communication for targeted protection from heart failure.
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Risk factors of cardiovascular and cerebrovascular diseases and pharmacological possibilities of their influence
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Cerebral energy metabolism studied by magnetic resonance spectroscopy as a basis for studying mechanisms of hypoxia-ischemic damage of the neonatal brain
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
  • Effect of natural compounds on the action of endogenous and exogenous oxidants
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
  • Molecular mechanisms of new drugs influencing oxidative stress - important ethiopathogenetic factor of numerous diseases
    Program: SRDA
    Duration: 1. 9. 2006 – 31. 10. 2009
  • Protection of the heart against malignant arrhythmias and heart failure.
    Program: SRDA
    Duration: 2. 5. 2006 – 30. 4. 2009
  • Protection of the heart against malignant arhythmis and heart failure
    Program: SRDA
    Duration: 1. 1. 2006 – 31. 12. 2008
  • Specific antagonists myocardial production and secretion of p roinflammatory cytokines(IC), expression of mitogenic vasopressor peptides (MP), polyferation and pathological remodelation after myocardial infarction (MI) and in chroni heart failure (CHF)
    Program: VEGA
    Duration: 1. 1. 2005 – 1. 12. 2007
Employees